Effect of nitric oxide synthase inhibition in experimental Pseudomonas keratitis in rabbits

European Journal of Ophthalmology

Volumn 8, Issue 3, 1998, Pages 137-141

  Er, H ^a   Turkoz, Y ^a   Ozerol, I H ^a   Uzmez, E ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Ciprofloxacin; Keratitis; L NAME; Nitric Oxide; Pseudomonas

Indexed keywords

BALANCED SALT SOLUTION; CIPROFLOXACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; KERATITIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; QUANTITATIVE DIAGNOSIS; RABBIT; SCORING SYSTEM; SLIT LAMP; SUBCONJUNCTIVAL DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION;

EID: 0031750660     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067219800800303     Document Type: Article

References (24)

1. Donnenfeld ED, Cohen EJ, Arentsen JJ, Genvert GI, Laibson PR. Changing trends in contact lens associated corneal ulcers: an overview of 116 cases. CLAO J 1986; 12: 145-9.
2. Cohen EJ, Fulton JC, Hoffman CJ, Rapuano CJ, Laibson PR. Trends in contact lens-associated corneal ulcers. Cornea 1996; 15: 566-70.
3. Mondino BJ, Weissman BA, Farb MD, Pettit TH. Corneal ulcers associated with daily-wear and extended-wear contact lenses. Am J Ophthalmol 1986; 102: 58-65.
4. Elgebaly SA, Miano DC, Kreutzer DL, Fishman JB. Cornea derived neutrophil chemotactic factors: intracellular synthesis and release. Curr Eye Res 1990; 9: 839-45.
5. Trinkaus-Randall V, Leibowitz HM, Ryan WJ, Kupferman A. Quantification of stromal destruction in the inflamed cornea. Invest Ophthalmol Vis Sci 1991; 32: 603-9.
6. Leibowitz HM, Ryan WJ, Kupferman A, De Santis L. Effect of concurrent topical corticosteroid and NSAID therapy of experimental keratitis. Invest Ophthalmol Vis Sci 1986; 27: 1226-9.
7. Hobden JA, O'Callaghan RJ, Hill JM, Hagenah M, Insler MS, Reidy JJ. Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis. Curr Eye Res 1992; 11: 259-66.
8. Mandai M, Yoshimura N, Yoshida M, Iwaki M, Honda Y. The role of nitric oxide synthase in endotoxin-induced uveitis: effects of NG-nitro L-arginine. Invest Ophthalmol Vis Sci 1994; 35: 3673-9.
9. Ostwald P, Goldstein IM, Pachnanda A, Roth S. Effect of nitric oxide synthase inhibition on blood flow after retinal ischemia in cats. Invest Ophthalmol Vis Sci 1995; 36: 2396-403.
10. Goureau O, Bellot J, Thillaye B, Courtois Y, de Kozak Y. Increased nitric oxide production in endotoxin-induced uveitis: Reduction of uvetis by an inhibitor of nitric oxide synthase. J Immunol 1995; 154: 6518-23.
11. Mandai M, Mittag TW, Kogishi J, Iwaki M, Hangai M, Yoshimura N. Role of nitric oxide synthase isozymes in endotoxin-induced uveitis. Invest Ophthaimol Vis Sci 1996; 37: 826-32.
12. Orpana AK, Avela K, Ranta V, Viinikka L, Ylikorkala O. The calcium-dependent nitric oxide production of human vascular endothelial cells in preeclampsia. Am J Obstet Gynecol 1996; 174: 1056-60.
13. Gwon A, Mantras C, Gruber L, Cunanan C. Concanavalin A-induced posterior subcapsular cataract: a new model of cataractogenesis. Invest Ophthalmol Vis Sci 1993; 34: 3483-8.
14. Alfonso E, Mandelbaum S, Fox MJ, Forster RK. Ulcerative keratitis associated with contact lens wear. Am J Ophthalmol 1986; 101: 429-33.
15. Stern GA. Update on the medical management of corneal and external eye diseases, corneal transplantation, and keratorefractive surgery. Ophthalmology 1988; 95: 842-54.
16. Hobden JA, O'Callaghan RJ, Hill JM, Reidy JJ, Rootman DS, Thompson HW. Tobramycin iontophoresis in-to corneas infected with drug-resistant Pseudomonas aeruginosa. Curr Eye Res 1989; 8: 1163-9.
17. Silbiger J, Stern GA. Evaluation of corneal collagen shields as a drug delivery device for the treatment of experimental Pseudomonas keratitis. Ophthalmology 1992; 99: 889-92.
18. Hobden JA, Engel LS, Hill JM, Callegan MC, O'Callaghan RJ. Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res 1993; 12: 469-73.
19. Wang ZY, Hakanson R. Role of nitric oxide (NO) in ocular inflammation. Br J Pharmacol 1995; 116: 2447-50.
20. Nathanson JA, McKee M. Alterations of ocular nitric oxide synthase in human glaucoma. Invest Ophthalmol Vis Sci 1995; 36: 1774-84.
21. El-Defrawy SR. Nitric oxide: a unique biologic mediator. Can J Ophthalmol 1997; 32: 12-6.
22. Mulligan MS, Moncada S, Ward PA. Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis. Br J Pharmacol 1992; 107: 1159-62.
23. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
24. Moore WM, Webber RK, Jerome GM, Tjoeng FS, Misko TP, Currie MG. L-N6-(I-iminoethyl) lysine: a selective inhibitor of inducible nitric oxide synthase. J Med Chem 1994; 37: 3886-8.